1. Home
  2. CADL vs NRIM Comparison

CADL vs NRIM Comparison

Compare CADL & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.88

Market Cap

551.7M

Sector

Health Care

ML Signal

HOLD

NRIM

Northrim BanCorp Inc

HOLD

Current Price

$23.39

Market Cap

531.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
NRIM
Founded
1999
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
551.7M
531.6M
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
CADL
NRIM
Price
$8.88
$23.39
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
2.2M
82.5K
Earning Date
05-14-2026
04-22-2026
Dividend Yield
N/A
2.62%
EPS Growth
58.62
N/A
EPS
N/A
0.61
Revenue
$125,000.00
$255,581,000.00
Revenue This Year
N/A
$4.98
Revenue Next Year
N/A
$7.40
P/E Ratio
N/A
$38.74
Revenue Growth
N/A
30.43
52 Week Low
$4.35
$19.60
52 Week High
$9.26
$99.18

Technical Indicators

Market Signals
Indicator
CADL
NRIM
Relative Strength Index (RSI) 75.99 41.61
Support Level $4.80 $22.46
Resistance Level N/A $25.52
Average True Range (ATR) 0.52 0.67
MACD 0.18 -0.17
Stochastic Oscillator 84.41 10.87

Price Performance

Historical Comparison
CADL
NRIM

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.

Share on Social Networks: